Integumentary System |
Skin |
Control |
17 MG/ML |
5 |
17 |
17 |
10 |
1 |
Inflammation |
Mild, Focal, Chronic Active |
Moribund Sacrifice |
Integumentary System |
Skin |
Control |
17 MG/ML |
5 |
20 |
20 |
11 |
1 |
Inflammation |
Minimal, Focal, Chronic Active |
Moribund Sacrifice |
Integumentary System |
Skin |
Control, Epidermis |
17 MG/ML |
5 |
20 |
20 |
11 |
1 |
Necrosis |
Minimal, Focal |
Moribund Sacrifice |
Integumentary System |
Skin |
Dermis, SOA |
17 MG/ML |
5 |
19 |
19 |
17 |
1 |
Edema |
Moderate, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
2 MG/ML |
5 |
6 |
6 |
17 |
1 |
Hyperplasia |
Minimal, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
2 MG/ML |
5 |
7 |
7 |
17 |
1 |
Hyperplasia |
Minimal, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
2 MG/ML |
5 |
9 |
9 |
17 |
1 |
Hyperplasia |
Minimal, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
11 |
11 |
17 |
1 |
Hyperplasia |
Minimal, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
12 |
12 |
17 |
1 |
Hyperplasia |
Moderate, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
13 |
13 |
17 |
1 |
Hyperplasia |
Mild, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
14 |
14 |
17 |
1 |
Hyperplasia |
Moderate, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
16 |
16 |
11 |
1 |
Hyperplasia |
Moderate, Diffuse |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
19 |
19 |
17 |
1 |
Hyperplasia |
Moderate, Diffuse |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
6 MG/ML |
5 |
12 |
12 |
17 |
1 |
Necrosis |
Mild, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
16 |
16 |
11 |
1 |
Necrosis |
Moderate, Focal |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
17 |
17 |
10 |
1 |
Necrosis |
Moderate, Focal |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
18 |
18 |
11 |
1 |
Necrosis |
Marked, Diffuse |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
20 |
20 |
11 |
1 |
Necrosis |
Marked |
Moribund Sacrifice |
Integumentary System |
Skin |
Epidermis, SOA |
17 MG/ML |
5 |
19 |
19 |
17 |
1 |
Necrosis |
Mild, Focal |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
6 MG/ML |
5 |
12 |
12 |
17 |
1 |
Inflammation |
Mild, Focal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
6 MG/ML |
5 |
14 |
14 |
17 |
1 |
Inflammation |
Minimal, Focal, Chronic Active |
Terminal Sacrifice |
Integumentary System |
Skin |
SOA |
17 MG/ML |
5 |
16 |
16 |
11 |
1 |
Inflammation |
Mild, Focal, Chronic Active |
Moribund Sacrifice |
Integumentary System |
Skin |
SOA |
17 MG/ML |
5 |
17 |
17 |
10 |
1 |
Inflammation |
Moderate, Diffuse, Chronic Active |
Moribund Sacrifice |
Integumentary System |
Skin |
SOA |
17 MG/ML |
5 |
19 |
19 |
17 |
1 |
Inflammation |
Moderate, Diffuse, Chronic Active |
Terminal Sacrifice |